DAE logo

Dätwyler Holding AG Stock Price

SWX:DAE Community·CHF 2.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

DAE Share Price Performance

CHF 153.60
32.40 (26.73%)
CHF 178.00
Fair Value
CHF 153.60
32.40 (26.73%)
13.7% undervalued intrinsic discount
CHF 178.00
Fair Value
Price CHF 153.60
AnalystConsensusTarget CHF 178.00
AnalystHighTarget CHF 185.00
AnalystLowTarget CHF 143.00

DAE Community Narratives

AnalystConsensusTarget·
Fair Value CHF 178 13.7% undervalued intrinsic discount

High-value Healthcare And Electric Vehicles Will Transform Future Markets

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystHighTarget·
Fair Value CHF 185 17.0% undervalued intrinsic discount

Accelerating Electrification And Miniaturized Healthcare Will Unlock Advanced Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value CHF 143 7.4% overvalued intrinsic discount

Rising Costs And Supply Risks Will Limit Future Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 178
13.7% undervalued intrinsic discount
Revenue
5.14% p.a.
Profit Margin
10.42%
Future PE
26.76x
Price in 2029
CHF 209.57

Trending Discussion

Updated Narratives

DAE logo

DAE: Collaboration In Drug Delivery Will Support Steady Long Term Outlook

Fair Value: CHF 143 7.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DAE logo

DAE: Outlook Will Balance Drug Delivery Collaboration With Moderated Profit Expectations

Fair Value: CHF 178 13.7% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DAE logo

DAE: Large Volume Drug Delivery Collaboration Will Support Attractive Future Share Upside

Fair Value: CHF 185 17.0% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Proven track record with adequate balance sheet and pays a dividend.

2 Risks
2 Rewards

Dätwyler Holding AG Key Details

CHF 1.1b

Revenue

CHF 842.6m

Cost of Revenue

CHF 257.9m

Gross Profit

CHF 177.1m

Other Expenses

CHF 80.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 23, 2026
4.75
23.43%
7.34%
136.6%
View Full Analysis

About DAE

Founded
1915
Employees
7823
CEO
Volker Cwielong
WebsiteView website
www.datwyler.com

Dätwyler Holding AG engages in the production and sale of elastomer components for healthcare, automotive, industries, and food and beverage industries in Switzerland, rest of Europe, North and South America, Asia, and internationally. It operates in two divisions, Healthcare and Industrial. The Healthcare division offers rubber components for prefilled syringes, pens, and injection systems; components and closures for injectable drugs in vials; and rubber components for blood collection systems, IV administration sets, disposable syringes, diagnostics and medical devices, etc. The Industrial division provides batteries and powertrains in electric vehicles, brake systems, interior and active assistance and safety systems in various cars, as well as fuel and engine management and exhaust gas aftertreatment in combustion engines; seals and components for electrical connectors; sealing solutions; and sealing components for upstream systems in the oil and gas, aerospace, heavy machinery, power tools and process, and water treatment industries. The company was founded in 1915 and is based in Altdorf, Switzerland. Dätwyler Holding AG is a subsidiary of Pema Holding AG.

Recent DAE News & Updates

Recent updates

No updates